IP Library › Granted Patent US 9,968,583
Granted Patent B2
US 9,968,583 · App. 13/260,864 · Granted May 15, 2018

Method of manufacture of liposome composition

Inventors: Hiroshi Kikuchi (Tsukuba, JP); Kenji Hyodo (Tsukuba, JP); Hiroshi Ishihara (Tsukuba, JP)
Assignee: EISAI R & D MANAGEMENT CO., LTD.
A61K31/337A61K9/1271A61K9/1278A61K31/704A61K31/7048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,583
App. No.
13/260,864
Granted
May 15, 2018
Kind
B2
Abstract

The present invention provides a method of manufacture of a liposome composition including a step in which: a liposome dispersion liquid containing a liposome, and further containing cyclodextrin in the liposome internal phase is provided and a step in which an active compound is introduced into said liposome internal phase, and the liposome composition.

Claims (12)

1. A method for preparing a liposome composition, comprising:

(a) preparing a liposome dispersion liquid comprising liposome and further comprising cyclodextrin in both the liposome internal phase and the liposome external phase;

(b) preparing a solution comprising an active compound and/or pharmaceutically acceptable salt thereof;

(c) mixing the liposome dispersion liquid prepared in (a) with the solution prepared in (b), thus preparing a mixed solution that has a higher concentration of cyclodextrin in the liposome internal phase than in the liposome external phase;

(d) heating the mixed solution prepared in (c) to a temperature equal to or higher than the liposome's lipid bilayer phase transition temperature; and

(e) obtaining, from the mixed solution of (d), a liposome composition that comprises the active compound complexed with the cyclodextrin in the liposome internal phase,

wherein the liposome in (a) is formed in a cyclodextrin-containing solution;

wherein the cyclodextrin is selected from the group consisting of hydroxypropyl-β-cyclodextrin, hydroxypropyl-γ-cyclodextrin, 6-O-maltosyl-β-cyclodextrin and sufobutylether-β-cyclodextrin; and

wherein the liposome's membrane comprises phospholipids that comprise saturated or unsaturated fatty-acid residues with a carbon number of 12 to 20.

2. The method according to claim 1 , wherein (a) preparing the liposome dispersion liquid further comprises: substituting or diluting the liposome external phase of the liposome dispersion liquid prepared in (a) with a liposome external phase that is cyclodextrin-free or that results in a liposome dispersion liquid that has a higher concentration of cyclodextrin the liposome internal phase than in the liposome external phase.

3. The method according to claim 1 , wherein the temperature equal to or higher than the liposome's lipid bilayer phase transition tempera u is from 20 to 100° C.

4. The method according to claim 1 , wherein the temperature equal to or higher than the liposome's lipid bilayer phase transition temperature is from 40 to 80° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2011
From: KIKUCHI, HIROSHI; HYODO, KENJI; ISHIHARA, HIROSHI
To: EISAI R & D MANAGEMENT CO., LTD.
Reel/Frame 027314/0805 →
Priority Claims (2)
JP 2009-082516 · Mar 30, 2009 · national
JP 2009-082521 · Mar 30, 2009 · national
Continuity (3)
Provisional Application 61164653 · Mar 30, 2009
Provisional Application 61164678 · Mar 30, 2009
Related Publication 20120128757A1 · May 24, 2012